...
首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >BRO beta-lactamase alleles, antibiotic resistance and a test of the BRO-1 selective replacement hypothesis in Moraxella catarrhalis.
【24h】

BRO beta-lactamase alleles, antibiotic resistance and a test of the BRO-1 selective replacement hypothesis in Moraxella catarrhalis.

机译:BROβ-内酰胺酶等位基因,抗生素耐药性和卡他莫拉菌中BRO-1选择性替代假说的检验。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: The hypothesis that BRO-1 selectively replaced the BRO-2 isoform of the Moraxella catarrhalis BRO beta-lactamase was tested by examining the temporal distribution, antibiotic resistance and epidemiological characteristics of isolates from a long-term collection at a single locale. METHODS: A rapid, one-step PCR assay conducted on 354 isolates spanning 1984-1994 distinguished bro alleles in over 97% of the beta-lactamase-producing isolates. Probes of dot blots were used to distinguish PCR failure from non-beta-lactamase-mediated penicillin resistance. RESULTS: BRO-2 isolates comprised 0-10% of the population per year with no evidence of a decline over time. All beta-lactamase producers exceeded the clinical threshold for penicillin resistance. Bimodality of penicillin MICs for beta-lactamase producers was caused by variation within BRO-1 rather than differences between BRO-1 and BRO-2. Non-beta-lactamase factors also confer resistance to penicillin and may contribute to the BRO-1 bimodality.The 13 BRO-2 isolates were associated with diverse genotypes within which there was evidence of epidemiologically linked clusters. The exclusive association of BRO-2 with four unrelated genotypes suggested maintenance of BRO-2 by recurrent mutation or horizontal exchange. CONCLUSIONS: The relative rarity of BRO-2 throughout the study, the absence of a declining temporal trend, and genetic diversity within BRO-2 all failed to support the hypothesis that BRO-2 was more common in the past and has been selectively replaced by BRO-1.
机译:目的:通过检查单个地点长期收集的分离株的时间分布,抗生素耐药性和流行病学特征,检验了BRO-1选择性替代卡他莫拉菌BROβ-内酰胺酶的BRO-2亚型的假设。方法:对跨越1984-1994年的354个分离株进行了快速的一步PCR测定,在97%以上的产生β-内酰胺酶的分离株中都鉴定出了等位基因。点印迹探针用于区分PCR失败与非β-内酰胺酶介导的青霉素耐药性。结果:BRO-2分离株每年占人口的0-10%,没有随时间下降的迹象。所有的β-内酰胺酶生产者都超过了青霉素耐药的临床阈值。青霉素MIC对β-内酰胺酶生产者的双峰性是由BRO-1内的差异而不是BRO-1和BRO-2之间的差异引起的。非β-内酰胺酶因子还赋予了对青霉素的抗性,并可能有助于BRO-1双峰。13种BRO-2分离株与多种基因型相关,其中存在流行病学相关簇的证据。 BRO-2与四种不相关基因型的排他性联系表明通过反复突变或水平交换可以维持BRO-2。结论:整个研究中BRO-2的相对稀有性,缺乏时空趋势的下降以及BRO-2内的遗传多样性均未能支持BRO-2在过去更为普遍且已被BRO-2选择性取代的假设。 BRO-1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号